Phase 2 study of cobimetinib in combination with vemurafenib in active melanoma brain metastases (coBRIM-B) - Yee, M K; Lin, Y (Poster Session 2015 ASCO Annual Meeting/Chicago 2015; Abstract # TPS9088, 2015)
et al.